Similar articles

• Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.

  Pollak A, Hayde M, Hayn M, Herkner K, Lombard KA, Lubec G, Weninger M, Widness JA. Pollak A, et al. Pediatrics. 2001 Jan;107(1):78-85. doi: 10.1542/peds.107.1.78. Pediatrics. 2001. PMID: 11134438 Clinical Trial.
• Erythropoietin and iron therapy for preterm infants.

  Vento M, Viña J, Asensi M. Vento M, et al. J Pediatr. 1999 Apr;134(4):520; author reply 521-2. doi: 10.1016/s0022-3476(99)70217-9. J Pediatr. 1999. PMID: 10190933 No abstract available.
• Oral iron supplementation in preterm infants treated with erythropoietin.

  Fujiu T, Maruyama K, Koizumi T. Fujiu T, et al. Pediatr Int. 2004 Dec;46(6):635-9. doi: 10.1111/j.1442-200x.2004.01979.x. Pediatr Int. 2004. PMID: 15660859 Clinical Trial.
• Iron supplementation in the intensive care unit: when, how much, and by what route?

  Lapointe M. Lapointe M. Crit Care. 2004;8 Suppl 2(Suppl 2):S37-41. doi: 10.1186/cc2825. Epub 2004 Jun 14. Crit Care. 2004. PMID: 15196322 Free PMC article. Review.
• The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy.

  Goodnough LT. Goodnough LT. Nephrol Dial Transplant. 2002;17 Suppl 5:14-8. doi: 10.1093/ndt/17.suppl_5.14. Nephrol Dial Transplant. 2002. PMID: 12091601 Review.